![1]()
News
FDA approves omadacycline for pneumonia and skin infections
October 4, 2018
The tetracycline antibiotic was approved for CABP and acute bacterial skin and skin structure infections in adults.
![1]()
News
Point-of-care test for respiratory viruses lowers antibiotic use
September 27, 2018
PARIS – In patients presenting with respiratory infections, a point-of-care test for viral infections has been associated with a reduction in unnecessary admissions and antibiotics, saving resources and improving quality of care.
News
Atrial fib guidelines may fall short on oral anticoagulation
September 25, 2018
Oral anticoagulation threshold according to CHA2DS2-VASc score varied widely after accounting for varying stroke rates in published studies.
![1]()
News
Severe influenza increases risk of invasive pulmonary aspergillosis in the ICU
September 22, 2018
ICU admission for severe influenza was an independent risk factor with correspondingly higher mortality rates resulting.
![1]()
News
Troponin I: Powerful all-cause mortality risk marker in COPD
September 21, 2018
PARIS – The relationship between increased troponin I and increased all-cause mortality was observed in an on-going prospective multicenter cohort.
![1]()
News
Most in-hospital pneumonia deaths may not be preventable
September 20, 2018
Adults who are hospitalized with community-acquired pneumonia (CAP) are at high-risk for short-term mortality.
![1]()
News
Expert panel updates guidelines on antithrombotic therapy for AF
September 18, 2018
The new guidelines highlight 60 key recommendations from the 12-person expert panel.
![1]()
News
Azithromycin for COPD exacerbations may reduce treatment failure
September 17, 2018
PARIS – Started when patients with COPD are hospitalized for an exacerbation, a 90-day course of azithromycin improved multiple outcome measures in a placebo-controlled trial.
![1]()
News
Review protocols, follow reprocessing guidelines to cut device-related HAIs
September 11, 2018
Environmental pathogens associated with medical devices or device reprocessing are often the cause of HAI-related investigations.
![1]()
News
Single-dose influenza drug baloxavir similar to oseltamivir in efficacy
September 5, 2018
A new single-dose influenza antiviral drug has similar time to symptom alleviation compared with oseltamivir, but greater reductions in viral load.
